Related by context. All words. (Click for frequent words.) 77 paclitaxel eluting stents 76 TAXUS Express Stent 75 sirolimus eluting stents 73 everolimus eluting stent 71 carotid endarterectomy CEA 71 morphometric vertebral fractures 71 binary restenosis 71 IOP lowering 70 CYPHER Stent 70 sirolimus eluting 70 PROMUS Element Stent 70 CYPHER R Sirolimus eluting 70 unresectable tumors 69 TAXUS Liberte Stent 69 eluting stent 69 carotid artery stenting CAS 69 transfemoral 69 XIENCE V PROMUS Stent 69 SYNERGY Stent 69 TAXUS Liberte Long 69 nondiabetic patients 69 GORE VIABAHN Endoprosthesis 69 zotarolimus 69 mm Stent 69 Cypher Stent 69 paclitaxel eluting stent 69 DAPT 68 VELCADE melphalan 68 dalteparin 68 angiographic restenosis 68 RE LY ® 68 XIENCE V demonstrated 68 NEVO ™ 68 MitraClip device 68 XIENCE V stent 68 multicenter randomized controlled 68 NPH insulin 68 carotid artery stenting 68 unfractionated heparin UFH 68 oncologic outcomes 68 nicardipine 68 symptomatic carotid stenosis 68 FOLFOX4 68 β blockers 67 antiarrhythmic drug 67 sorafenib Nexavar 67 CIMZIA ™ 67 lipid lowering agents 67 hemodynamically significant 67 ARB telmisartan 67 reinfarction 67 concurrent chemoradiation 67 MiStent DES 67 analgesic efficacy 67 relapsed MM 67 clodronate 67 Vascular Wrap 67 angiographic outcomes 67 symptomatic VTE 67 ancrod 67 irbesartan 67 chemoradiation therapy 67 Non inferiority 67 Heparin Bioactive Surface 67 OPCAB 67 ABSORB trial 67 zotarolimus eluting stent 67 intracranial stenosis 67 doxorubicin docetaxel 67 ATACAND 67 prospectively stratified 67 pain palliation 66 certolizumab 66 CIMZIA TM certolizumab pegol 66 postoperative mortality 66 carotid stenting 66 Doxil ® 66 lanthanum carbonate 66 fondaparinux 66 GP IIb IIIa inhibitors 66 sirolimus eluting stent 66 recurrent GBM 66 debulking surgery 66 CYPHER ® 66 ZoMaxx 66 patients undergoing CABG 66 secondary efficacy endpoint 66 periprocedural 66 pegylated liposomal doxorubicin 66 platelet inhibitor 66 radial artery grafts 66 TAXUS TM 66 dose atorvastatin 66 5-fluorouracil/leucovorin 66 sunitinib Sutent 66 Taxus Stent 66 MIST II 66 plus prednisone 66 hyperphenylalaninemia HPA due 66 saphenous vein grafts 66 locoregional recurrence 66 serum calcium levels 66 SPIRIT FIRST 66 atorvastatin #mg 66 recurrent glioblastoma multiforme 66 pioglitazone HCl 66 elective PCI 66 percutaneous transluminal coronary angioplasty 66 Octreolin 66 noninferior 66 graft occlusion 66 stent DES 66 prospective multicenter randomized 66 Sirolimus eluting 66 definite stent thrombosis 66 defibrillator CRT D 66 postoperative chemotherapy 66 colesevelam HCl 66 coronary stenting 66 pCR 66 percutaneous intervention 66 allogeneic hematopoietic stem cell 66 renal artery stenting 66 abacavir lamivudine 66 melphalan prednisone 65 Combo Stent 65 TAXUS Stent 65 Gliadel Wafer 65 ischemic cardiomyopathy 65 QuadraSphere 65 placebo controlled clinical 65 ULORIC 65 stenoses 65 Thal Dex 65 Cypher Sirolimus 65 coronary revascularization 65 photocoagulation 65 oral rivaroxaban 65 intravesical therapy 65 deferiprone 65 Eluting Stent 65 levosimendan 65 STRIDE PD 65 rFVIIa 65 liposomal doxorubicin 65 Free Survival PFS 65 CRESTOR #mg 65 MGd 65 adjuvant radiotherapy 65 KRAS mutations occur 65 catheter occlusion 65 basal bolus regimen 65 standard chemotherapy regimen 65 cytoreductive surgery 65 BENICAR HCT 65 aldosterone antagonist 65 transapical 65 insulin detemir 65 GORE TAG Device 65 NATRECOR ® 65 autologous chondrocyte implantation 65 ALA PDT 65 postmenopausal osteoporotic women 65 SYNTAX trial 65 colorectal liver metastases 65 ACCORD Lipid 65 NEVO 65 candesartan cilexetil 65 drug eluting stent DES 65 systemic immunosuppressive drugs 65 thromboembolic complications 65 Bivalirudin 65 acute STEMI 65 endarterectomy 65 ARIXTRA 65 pimecrolimus 65 Retisert 65 ACUITY trial 65 pulmonary artery banding 65 nonrandomized 65 glycoprotein IIb IIIa inhibitors 65 arterial grafts 65 complete cytogenetic response 65 TAXUS Liberté stent 65 primary patency 65 BrachySil TM 65 stage IIIb IV 65 fosamprenavir 65 non valvular atrial 65 CLARITY study 65 Vascugel ® 65 thrombus aspiration 65 aspirin clopidogrel 65 WallFlex Biliary RX 65 MADIT II 65 biochemical relapse 65 salmeterol fluticasone 65 Edwards SAPIEN valve 65 revascularized 65 Renal Cell Carcinoma RCC 65 latanoprost 65 serum phosphorous 65 uncoated stent 65 chlorambucil 64 asymptomatic carotid stenosis 64 functional mitral regurgitation 64 nephron sparing surgery 64 unfractionated heparin 64 Elitek 64 graft patency 64 Xelox 64 Zilver PTX stent 64 fibrinolytic therapy 64 deferoxamine 64 paricalcitol 64 NAVISTAR R 64 Long Lesion 64 pravastatin therapy 64 liver resection 64 tirofiban 64 EURIDIS 64 docetaxel Taxotere ® 64 Dabigatran 64 drug eluting stent implantation 64 carotid IMT 64 histologically confirmed 64 oblimersen 64 ximelagatran 64 Randomized Evaluation 64 sipuleucel T 64 pamidronate 64 HoLEP 64 Coronary Artery Bypass Graft 64 ExTRACT TIMI 64 dosage regimens 64 rt PA 64 superficial femoral 64 systemic embolism 64 Fondaparinux 64 NSTE ACS 64 biphasic insulin aspart 64 paclitaxel eluting 64 Losartan 64 postoperative morbidity 64 hsCRP levels 64 inhaled treprostinil 64 Ranibizumab 64 antiplatelet agent 64 Stent thrombosis 64 antiangiogenic agent 64 Zilver PTX 64 hepatic resection 64 FFR guided treatment 64 Carotid Revascularization Endarterectomy vs. 64 Epanova 64 Acute Ischemic Stroke 64 radical nephrectomy 64 PRECISE 64 EchoCRT 64 chemoembolization 64 tenecteplase 64 drotrecogin alfa activated 64 Endeavor DES 64 #:# randomization 64 Procoralan 64 prostate TURP 64 neoadjuvant 64 MAGE A3 ASCI 64 tapentadol ER 64 flutamide 64 MACUGEN 64 5-FU/LV 64 radiochemotherapy 64 IIIa inhibitor 64 transthoracic 64 prospective multicenter study 64 FOSRENOL ® 64 Tarceva TM 64 lispro 64 strontium ranelate 64 PERSEUS 64 revascularization procedures 64 intima media thickness 64 noninferiority 64 low dose Iluvien 64 CYPHER ® Stent 64 Platinol ® cisplatin 64 cisplatin vinorelbine 64 adjuvant radiation 64 perioperative mortality 64 Eluting Coronary Stent System 64 rosuvastatin #mg 64 invasive candidiasis 64 Transcatheter aortic valve implantation 64 oral diclofenac 64 hemostatic efficacy 64 tacrolimus ointment 64 zoledronate 64 interferon gamma 1b 64 phase IIIb 64 recurrent NSCLC 64 CINQUIL 64 antiplatelet drugs 64 AFRS TM 64 azacitidine 64 refractory angina 64 hepatic metastases 64 Kaplan Meier analysis 64 tenofovir emtricitabine 64 CA9 SCAN 64 parecoxib 64 clopidogrel Plavix 64 vinorelbine 64 neurologic progression 64 radiotherapy RT 64 sargramostim 64 CINTREDEKIN BESUDOTOX 64 oxycodone CR 64 multicentre randomized 64 Burch colposuspension 64 somatostatin analog 64 XELOX 64 deep venous thromboses 64 neointimal hyperplasia 64 dacarbazine chemotherapy 64 RSD# oral 64 valve implantation 64 neoadjuvant therapy 64 hypogonadal men 64 metastatic malignant 64 TAXUS VI 64 thoracoscopic lobectomy 64 LHRH receptor positive 64 PROMUS 64 GP IIb IIIa inhibitor 64 eptifibatide 64 Intravitreal 63 Platinol 63 Flu Cy 63 perioperative complications 63 dacarbazine 63 thromboprophylaxis 63 percutaneous vertebroplasty 63 transcatheter aortic valve implantation 63 oral ridaforolimus 63 atrioventricular block 63 TLUS 63 gemcitabine Gemzar 63 bypass grafting 63 aldosterone antagonists 63 trabeculectomy 63 oral anticoagulation 63 CARE HF 63 lung resection 63 reduce serum phosphate 63 transcatheter closure 63 Platinum Chromium 63 cediranib 63 carotid artery stenosis 63 edifoligide 63 TAXUS Express Atom Stent 63 DCVax ® Brain 63 NATRECOR R 63 epoetin alpha 63 STARFlex R 63 CIMZIA TM 63 Sirolimus eluting Coronary Stent 63 Tacrolimus 63 vidofludimus 63 galiximab 63 evaluating tivozanib 63 Myocardial Infarction Study 63 carotid revascularization 63 Biolimus A9 63 sirolimus stent 63 CYPHER ® Sirolimus eluting 63 confirmatory clinical 63 ipsilateral stroke 63 phakic 63 HepaSphere 63 XIENCE V Everolimus Eluting 63 perioperatively 63 idraparinux 63 carotid endarterectomy 63 metastatic HRPC 63 FUSILEV enhances 63 ablative therapy 63 Vascugel 63 carotid stents 63 briakinumab 63 bolus dose 63 resynchronization therapy 63 AGILECT R 63 fallopian tube cancers 63 esophagogastric 63 EDEMA3 trial 63 multivessel disease 63 urethral bulking agent 63 ZOLINZA 63 SCIg 63 teriflunomide 63 lumbar spine BMD 63 paroxysmal AF 63 PASI scores 63 stable angina 63 hematological parameters 63 TAXUS ® 63 preoperative chemotherapy 63 renal tumors 63 anti arrhythmic drug 63 preoperative radiotherapy 63 TNF antagonist 63 renal artery stenosis 63 liver histology 63 patients undergoing noncardiac 63 tipranavir r 63 tolvaptan 63 ARCOXIA 63 thrombolytic therapy 63 #.#/#.# mmHg [001] 63 saline placebo 63 nonoperative treatment 63 luminal diameter 63 liver transplant recipients 63 EOquin TM 63 adjuvant tamoxifen 63 pretransplant 63 Ranolazine 63 Nitinol Stent 63 undergoing coronary artery 63 arterial thrombosis 63 riociguat 63 dosing frequency 63 xanthine oxidase inhibitor 63 cystectomy 63 cardiac resynchronization 63 alteplase 63 urodynamic 63 prospectively defined 63 Drug eluting stent 63 sitaxsentan 63 docetaxel chemotherapy 63 APTIVUS r 63 Patients Treated With 63 #mg BID [001] 63 pancreatic adenocarcinoma 63 revascularizations 63 tamoxifen Nolvadex ® 63 active comparator 63 relapsed ALL 63 bevacizumab Avastin ® 63 MACCE 63 mycophenolic acid 63 PSA nadir 63 hoFH 63 Phase IIIb clinical 63 EBRT 63 Dabigatran etexilate 63 GAMMAGARD 63 placebo dexamethasone 63 NLX P# 63 HORIZONS AMI trial 63 lenalidomide Revlimid R 63 cryptogenic stroke 63 REMINYL ® 63 cardiac perfusion 63 NMIBC 63 comparator arm 63 carboplatin paclitaxel 63 IFN alfa 63 mL/min/#.# m 2 63 operable pancreatic cancer 63 Polyzene R F 63 atherosclerotic renal artery stenosis 63 relapsing multiple sclerosis 63 retinal vein occlusion induced 63 OZURDEX ® 63 reintervention 63 thalidomide Thalomid 63 metastatic GIST 63 workhorse lesions 63 Apidra ® 63 AngioJet thrombectomy 63 MoxDuo TM IR 63 transurethral resection 63 interferon alfa 2b 63 antithrombotic therapy 63 titrated glipizide 63 alfuzosin 63 paclitaxel Taxol ® 63 Zemplar Capsules 63 AA Amyloidosis 63 prostate carcinoma 63 CYT# potent vascular disrupting 63 ION Stent 63 macular edema secondary 63 randomized multicenter trial 63 TKM ApoB 63 anagrelide 63 clevidipine 63 infusional 63 rHuPH# 63 adrenalectomy 63 hypercholesterolemic patients 63 everolimus eluting 63 symptomatic intracranial 63 EXJADE 63 dyslipidaemia 63 radiographic outcomes 63 #.#mg/dL 63 oral FTY# 63 pharmacokinetic equivalence 63 INCB# [003] 63 weekly subcutaneous injections 63 Cotavance 62 tamsulosin 62 Protelos 62 LV dysfunction 62 PREZISTA r 62 brivaracetam 62 pyridostigmine 62 CABG surgeries 62 daily subcutaneous injections 62 severe aortic stenosis 62 LNG IUS 62 paroxetine sertraline 62 Ophena 62 Intra arterial 62 Surgical resection 62 carotid stenosis 62 demonstrated clinically meaningful 62 thienopyridine 62 Percutaneous Coronary Intervention 62 receiving prophylactic anticoagulation 62 subcutaneous enoxaparin 62 RAPAFLO R 62 baseline HbA1c 62 angioplasty stenting 62 thromboembolic events 62 ketorolac 62 GnRH agonists 62 VATS lobectomy 62 ACTEMRA TM 62 plus dexamethasone 62 postoperative radiotherapy 62 BeneFIX 62 bivalirudin 62 PFO closure 62 acetonide FA 62 tumor resection 62 MIVI III 62 diameter stenosis 62 microdebrider 62 mycophenolate mofetil 62 chlorthalidone 62 bovine thrombin 62 APTIVUS R 62 pegaptanib 62 STARFlex ® 62 IV NSCLC 62 mRCC 62 Angiographic 62 Patency 62 steroid refractory 62 thienopyridines 62 cranial irradiation 62 nonischemic 62 adjunctive placebo 62 cangrelor 62 micafungin 62 Thrombolysis 62 prostate cancer CRPC 62 SPIRIT III 62 GOUT 62 anticoagulated 62 infarct size 62 bypass graft CABG surgery 62 posterolateral fusion 62 mg/m2 dose 62 RoACTEMRA 62 eplerenone 62 CALGB # [002] 62 extracranial 62 Subgroup analysis 62 PSADT 62 nonoperative 62 interferon ribavirin 62 myoblast therapy 62 achieved CCyR 62 beta blocker therapy 62 nadolol 62 prospective multicenter 62 CaPre TM 62 bifurcated lesions 62 BrachySil ™ 62 cilostazol 62 BPS IC 62 IM progesterone 62 Operative mortality 62 underwent surgical resection 62 ibandronate 62 CoreValve System 62 Aggressive Drug Evaluation 62 docetaxel prednisone 62 Ozurdex 62 colorectal adenoma 62 subconjunctival injection 62 mCRC patients 62 adjuvant cisplatin 62 allogeneic HSCT 62 thrombolytics 62 mutated K ras 62 5 FU leucovorin 62 lipid lowering drugs 62 methotrexate monotherapy 62 Carotid 62 glycated hemoglobin levels 62 warfarin anticoagulation 62 CardioPass 62 R# #mg BID 62 CYPHER R Sirolimus Eluting 62 de novo lesions 62 transapical approach 62 Endarterectomy 62 TAXUS Express2 62 stent restenosis 62 eluting stents 62 octreotide LAR 62 endothelial keratoplasty 62 #mg doses [002] 62 androgen deprivation 62 repeat revascularization 62 Pegylated Liposomal Doxorubicin 62 bioprostheses 62 placebo controlled Phase III 62 pravastatin 62 Zyclara 62 drug eluting coronary stents 62 CTAP# Capsules 62 TAXUS p value 62 Target Lesion Revascularization TLR 62 prospective randomized controlled 62 epoprostenol 62 TAXUS V 62 antiretroviral naïve 62 ruboxistaurin 62 INTEGRILIN R 62 multicenter placebo controlled 62 ENDEAVOR III 62 angiographically 62 HBeAg seroconversion 62 chemoradiotherapy 62 Intravitreal injections 62 metastatic neuroendocrine tumors 62 smoldering multiple myeloma 62 cisplatin gemcitabine 62 cinacalcet 62 death reinfarction 62 TAXUS Element Stent 62 recombinant tissue plasminogen 62 urate lowering therapy 62 CIPN 62 Coronary Stent 62 splenectomized 62 fully bioabsorbable 62 Femara letrozole 62 evaluable subjects 62 ejection fractions 62 fosbretabulin 62 platinum chromium alloy 62 dose dexamethasone 62 TAXUS Express2 Paclitaxel Eluting 62 occlusive disease 62 subcutaneous immunoglobulin 62 metaglidasen 62 recanalization 62 Degarelix 62 Stenting 62 liver metastasis 62 aspirin heparin 62 colorectal metastases 62 XGEVA 62 interstitial brachytherapy 62 urinary N telopeptide 62 Atom Stent 62 surgical aortic valve 62 multicenter clinical 62 fluvastatin 62 gefitinib Iressa 62 oxymorphone ER 62 postoperative complication 62 prospective randomized multicenter 62 steroid dexamethasone 62 intracoronary 62 Combination therapy 62 Vidaza ® 62 reteplase 62 infliximab monotherapy 62 medically inoperable 62 NSABP B 62 anti angiogenic agents 62 adenoma recurrence 62 EDEMA3 62 hemodialysis patients 62 randomized blinded 62 NIHSS score 62 myelodysplastic myeloproliferative diseases 62 dose proportionality 62 transurethral 62 ezetimibe simvastatin 62 preventing restenosis 62 revascularization procedure 62 vorinostat 62 NSABP C 62 MIRAPEX 62 transplantation HCT 62 Insulin detemir 62 thrombolytic agent 62 intra arterial 62 keloid scarring 62 pharmacokinetic characteristics 62 Pemetrexed 62 AIM HIGH 62 CCyR 62 Ceplene/IL-2 62 Aptivus ® 62 FASLODEX 62 Abciximab 62 Irinotecan 62 replacement TAVR 62 Ophena TM 62 PEGINTRON TM 62 coronary interventions 62 TAXUS Liberte 62 vinorelbine tartrate 62 dipyridamole plus 62 RE LY 62 elevated LDH 62 Keppra XR 62 HYLENEX recombinant 62 aPTT 62 oral antidiabetic medication 62 pharmacodynamic properties 62 PROMUS TM 62 mitoxantrone plus 62 unstable angina UA 62 nab paclitaxel 62 TAXUS Element Paclitaxel Eluting 62 Anti Bacterial Envelope 62 Acute Decompensated Heart Failure 62 TAXUS Express 62 platelet reactivity 62 oxycodone IR 62 clazosentan 62 esophagectomy 62 Abbott bioabsorbable everolimus eluting 62 ziprasidone 62 antihypertensive therapy 62 tolterodine ER 62 primary percutaneous coronary 62 composite endpoint 62 valdecoxib 62 PERSEUS clinical program 61 endovascular repair 61 TACE 61 CTEPH 61 Aflibercept 61 bi ventricular pacing 61 Percutaneous Transluminal Coronary Angioplasty 61 AZT zidovudine Retrovir 61 Express LD Iliac 61 ß blockers 61 R sorafenib tablets 61 variceal hemorrhage 61 retrospective observational study 61 glycosylated hemoglobin levels 61 invasive aspergillosis 61 CHAMPION PCI 61 Azacitidine 61 divalproex sodium 61 ePTFE graft 61 lopinavir r 61 Randomized controlled 61 ACE inhibitor ramipril 61 bosentan 61 folinic acid 61 myocardial infarction stroke 61 intact parathyroid hormone 61 Resolute DES 61 squamous histology 61 factor Xa inhibitor 61 alkylating agent 61 treprostinil 61 recurrent VTE 61 candidemia 61 abciximab 61 vein grafts 61 oral anticoagulant therapy 61 vinca alkaloid 61 rimonabant #mg 61 endoscopic remission 61 beclomethasone dipropionate 61 prednisone prednisolone plus 61 unstable angina pectoris 61 Events MACE 61 elotuzumab 61 PressureWire 61 femoral popliteal 61 ritonavir boosted 61 Teriparatide 61 Accelerated Partial Breast Irradiation 61 coronary stent merged 61 mixed hyperlipidemia 61 restenotic lesions 61 Transcatheter 61 TUMT 61 nonfatal MI 61 induced macular edema 61 immunomodulatory agents 61 inhaled iloprost 61 r hGH 61 reslizumab 61 Carotid endarterectomy 61 FIRMAGON 61 mcg QD 61 decompensated heart failure 61 Initiate Clinical Trial 61 demonstrated antitumor activity 61 DASISION 61 eculizumab therapy 61 Vidaza azacitidine 61 clinically meaningful efficacy 61 cardiovascular hospitalizations 61 HDL Selective Delipidation 61 metastatic colorectal carcinoma 61 PICSO ® 61 recurrent malignant glioma 61 VTE prophylaxis 61 CANCIDAS 61 infrapopliteal 61 FDG PET imaging 61 virologic response 61 intraobserver 61 drug zotarolimus 61 underwent resection 61 HMG CoA reductase inhibitors 61 Nexavar sorafenib 61 tecarfarin 61 retransplantation 61 Resten NG 61 antiplatelet medications 61 CoFactor 61 paclitaxel Taxol R 61 calcaneal fractures 61 metastatic renal cell carcinoma 61 systemic hypotension 61 Intervention Effectiveness 61 docetaxel Taxotere 61 metformin monotherapy 61 intravitreal injections 61 undetectable HBV DNA 61 NeuroFlo 61 basiliximab 61 Coronary artery bypass graft 61 cTnI 61 intravenous bisphosphonates 61 carotid surgery 61 carotid artery blockage 61 desvenlafaxine succinate 61 Durezol 61 PTNS 61 artery embolization 61 brand ciclesonide HFA 61 neurologic outcomes 61 TEVAR 61 Androxal TM 61 Campath alemtuzumab 61 TO AVOID PREGNANCY WHILE 61 bioabsorbable polymer 61 multicenter prospective 61 amrubicin 61 balloon dilation 61 intravenous dosing 61 descending thoracic 61 intensive lipid lowering 61 Genous stent 61 iodixanol 61 echocardiographic parameters 61 transcatheter 61 Fully Covered Stent 61 cardiac resynchronisation therapy 61 V Everolimus Eluting Coronary 61 cardiac repolarization 61 biliary tract cancer 61 phase IIb clinical 61 perioperative morbidity 61 Meets Primary Endpoint 61 transarterial 61 bivalirudin monotherapy 61 Sapien valve 61 primary hypercholesterolemia 61 RRMS patients 61 multicenter randomized placebo controlled 61 BoNTA 61 Cleviprex TM clevidipine 61 KRN# 61 VESTAsync 61 posaconazole 61 ENDEAVOR II 61 CryoValve SG 61 saphenous vein graft 61 Stenting Trial CREST 61 antiangiogenic therapy 61 biologic DMARD 61 ROCKET AF 61 non splenectomized 61 HydroCoil 61 Edge STudy 61 colorectal cancer liver metastases 61 ACTOS ® 61 TORISEL 61 DEB# 61 BCR ABL inhibitor 61 INTEGRILIN 61 enalapril 61 insulin lispro 61 Resolute stent 61 carotid artery stent 61 doxorubicin cyclophosphamide 61 Islet transplantation 61 advanced adenomas 61 RECORD1 61 Nilotinib 61 tumor necrosis 61 laser photocoagulation 61 QVAR R 61 Ventavis ® 61 metastatic castration resistant 61 sirolimus 61 TAXUS stent 61 symptomatic intracranial hemorrhage 61 EmbraceAC 61 undergoing coronary angiography 61 Enoxaparin 61 osteoporotic compression fractures 61 Folfox 61 corneal ectasia 61 tricuspid valve repair 61 metastatic hormone refractory 61 metastatic RCC 61 prasugrel Effient 61 capecitabine Xeloda 61 HeartNet 61 intravenous diuretics 61 XIENCE 61 MEND CABG 61 DCCR 61 idarubicin 61 bioresorbable polymer 61 Temsirolimus 61 Amrubicin 61 TroVax ® 61 Carvedilol 61 Solesta 61 hepatectomy 61 azilsartan medoxomil 61 atherothrombotic events 61 Targretin capsules 61 LAGB 61 FDA defined valvulopathy 61 failure ADHF 61 PSMA ADC 61 TAVR 61 Ascendra 61 GEM OS2 61 Val HeFT 61 platelet inhibition 61 biochemical recurrence 61 novel VDA molecule 61 Augment Injectable 61 cardiovascular hospitalization 61 K ras mutations 61 timolol 61 rhBMP 2 61 fluoropyrimidine 61 EVIZON 61 valsartan 61 registrational Phase 61 canakinumab 61 abacavir Ziagen 61 CYPHER R Stent 61 inhibitor RG# 61 multicenter Phase III 61 efficacy tolerability 61 clinically localized prostate 61 dose cohort 61 mechanical thrombectomy 61 TLK# 61 Mitomycin C